pre-miRNA resulting in the 22 nucleotide double-stranded miRNA duplex. One strand, the guide strand, becomes incorporated into the RISC to target the 3' untranslated region of specific mRNAs for degradation or translation repression.
RNA interference
Gene expression is regulated at many levels in eukaryotes. RNA [18] . Also, cancer cell derived exosomes were shown to manipulate their environment for the optimization of growth conditions. They can promote therapy resistance, angiogenesis, tumor cell invasion and immune suppression [10] . Cancer cell released exosomes can contribute to the inhibition of natural killer cell activity [19] or the preparation of niches for metastatic spread [20] . To what extent miRNAs are involved in the observed effects is not yet clear.
Synthetic carriers for nucleic acid transfection
The major classes of synthetic carriers are shown in Table 1, together with the most pronounced advantages and drawbacks in their usage for siRNA transfection [21] [63] PEGylation decreased blood clearence [64] incorporation of fusogenic lipids enhanced bioavailability of siRNA [65] apolipoprotein A 95% knockdown without immunotoxicity targeted to the liver [66] pH-sensitive histidinelysine peptide inhibition of tumor growth in a pancreatic cancer model [67] peptide from Rabies Virus glycoprotein brain targeting [68] SNALPs -Stabilized Nucleic Acid Lipid Particles PEG-derivatized cationic lipid with stabilized lipid bilayer fusogenic prolonged blood circulation 80-90% efficiency after siRNA transfection into liver [34] SPANosomes sorbitan monooleate high siRNA incorporation efficiency efficient endosomal escape and cytosolic delivery 60-80% gene knockdown [69, 70] Polyethylenimine -PEI toxicity of high molecular weight PEI proton sponge effect for efficient release from endosomes [21] hydrophobic lipid anchor improved cellular uptake [71] folate folate receptor mediated uptake [42] galactose and pullulan liver targeted [43, 72] PEI-PEG-copolymer efficient siRNA release 75%gene knockdown efficiency suppression of tumor growth [73] bioreducible poly(amido ethylenimine) (SS-PAEI) complete release of siRNA in a reductive environment [62] Poly(dl-lactide-co-glycolide) -PLGA degraded under physiological conditions degradation rate can be controlled by composition of the polymer nucleic acid encapsulation no endosomal escape mechanism [74] cationic segments (polyamines) good binding and protections of siRNA disruption of endosomal membranes [75] poly(ethylene glycol)-poly (d,l-lactide) cationic lipic suppressed tumor growth in a breast cancer murine xenograft model [76] Chitosan biodegradable, no/low immunogenicity low siRNA transfection efficiency [77, 78] salt complexes excellent cell survival high gene silencing [79] α-tocopherol succinate enhanced cellular uptake [47] thiamine pyrophosphate >70% gene silencing [80] RGD peptide targeting to cancer cells [44] guanidinylation decreased cytotoxicity and enhanced cellular internalization of siRNA enhanced gene-silencing efficiency [46] linear(PEI-PEG) copolymer excellent biocompatibility remarkable transfection efficiency [81] Cyclodextrin no immunogenicity protection of siRNA no endosomal escape mechanism [82] imidazole groups enhanced intracellular delivery [52] polycations, PEG, targeting ligands effective, low-toxicity vehicle for delivering siRNA [83] Polycations like PEI or polycationic lipids are most commonly used for complexing nucleic acids. Although siRNAs show reduced strength of that interaction due to their short length, adaptations of the composition of transfection mixtures overcome that problem [21] .
Exosomes can be loaded with siRNA via two different paths:
intracellular during their genesis, or extracellular after their isolation and purification [22] . Native exosomes contain specific sets of miRNAs indicating that a biological selection process exists for selective vesicle packaging. Efficient use of the in vivo packaging route requires a better understanding of the selection process including the mechanism for intracellular trafficking and possibly cis-acting elements that target siRNAs and miRNAs into exosomes.
The second possibility, the in vitro loading of isolated exosomes with siRNA was successfully achieved by electroporation [26, 27] , though it might decrease their functionality by inducing aggregation. The siRNA load was subsequently released into the cytoplasm of target cells and resulted in specific gene silencing in animal models. To date, siRNA loading into exosomes is experimentally challenging and vesicles, and to form aggregates resulting in poor recovery as well as presumably reduced functionality [23] . The purity of exosome preparations can be improved by equilibrium density centrifugation. Immunoaffinity methods using exosome specific antibodies and magnetic particles were described yielding cell type-specific exosomes [24] . Also high performance liquid chromatography (HPLC) was successfully employed for the isolation of biologically active exosomes [22] . Precipitation of exosomes can avoid high speed centrifugations, but the obtained exosomes are hardly biologically active [25] . Until now, no cost effective, scalable purification method has been developed.
In contrast, the production of synthetic carriers is usually well suited for mass production with highly reproducible quality and variable costs. Without any doubt, synthetic carriers outcompete exosomes concerning cost effectiveness, scalability and consistent high quality production (Figure 1 ).
[Intermediate score: exosomes -synthetic carriers 0:1]
Loading
The binding of siRNA molecules to synthetic carriers is mediated by ionic interactions and is fast, simple and straightforward.
Polypeptides low cytotoxocity inefficient intracellular release [21] poly aspartamide pH-dependent endosome destabilization [84] stearoyl groups enhanced cellular uptake [48] cell penetrating peptides cholesteryl oligo-Darginine tumor regression [85, 86] histidine residues proton sponge activity [53] branched histidine-lysine >80% gene silencing [87] Dendrimers tunable structure, molecular size and surface charge [88] PAMAM (poly-amidoamine) cytotoxic good cellular uptake [89] PPI (poly-propylenimine) higher cytotoxicity [29] PEG-LHRH peptide coating increased serum resistance tumor-specific targeting effective cell penetration and silencing activity [45] Nanogels high loading capacity good protection of siRNA higher biodegradability = lower cytotoxicity [90] cross-linked PEG-PEI inefficient siRNA delivery [91] PDEAMA better endosomal escape [92] Gold nanoparticles coated with poly-β-aminoesters easy synthesis biocompatible >90% gene knockdown [93] [94] [95] [96] incorporation of PEI up to 60% silencing activity [97] Chitosan plus PEI siRNA protection efficient uptake facilitated escape [98] Carbon nanotubes easy surface functionalization [99, 100] amphiphilic polymer coating high gene silencing also in primary cells [101] Quantum-dots L-Arg or β-Cyclodextrin-L-Arg low cytotoxicity efficient protection of naked siRNA effective cellular uptake more than 80% gene silencing efficiency [102] In exosomes, RNA is perfectly protected from degradation, even after incubation of purified exosomes with RNase their RNA content was preserved [18] . In the bloodstream, exosomes are relatively stable and as naturally occurring vesicles their half-life is evolutionary optimized. They do not interact with opsonins, and coagulation and complement factors [8] . Besides the blood plasma, intact exosomes with full biological activity are also found in human urine [30] , breast milk [31] and bronchial lavage fluid [32] was shown to decrease blood clearance due to the hydrophilic nature of PEG which provides an aqueous shield around the liposome surface [28] . PEGylation was also used to increase the serum resistance of dendrimers [29] . PEI containing complexes have the tendency to accumulate in liver, lung, spleen and kidney leading to rapid removal from blood. This 
Left part: nucleic acid binding scaffolds and siRNA are synthesized and combined to yield transfection complexes which are then applied to the patient (current stage: clinical trials). Right part: The production of exosomes for siRNA transfection is more complex. Patient derived cells are transferred into tissue culture and the formed exosomes are isolated from the supernatant. Exosomes are loaded with siRNA e.g. by electroporation and then injected into the bloodstream (current stage: preclinical).
asialoglycoprotein receptor expressing liver cells [43] . Including RGD peptides into chitosan scaffolds permitted targeting to cancer cells [44] . Problems with tissue targeting can be circumvented sometimes by localized delivery of transfection complexes, i.e. direct injection into tumors.
Incorporation of ligands for cell surface receptors can also increase cellular uptake as shown for PEG-LHRH peptide coating of dendrimers [45] . In addition, non-specific enhancement of siRNA internalization can be achieved, for example by incorporation of fusogenic lipids. Guanidinylation or addition of α-tocopherol succinate enhanced the cellular uptake of chitosan complexes [46, 47] , whereas stearoyl groups facilitate cell penetration of polypeptides [48] . Some peptides have a natural cell penetration capability which can be linked to other molecular structures [49] .
Currently it seems that the question of targeting and cellular uptake can be solved with similar effort and success for exosomes and synthetic carriers.
[Intermediate score: exosomes -synthetic carriers 3:3]
4.6 RNA release PEI is therefore commonly added to liposomes, PLGA, or gold nanoparticles to improve endosomal release of siRNA.
The intracellular delivery of cyclodextrin complexes could be enhanced by imidazole groups [52] . Through a buffering mechanism similar to that of PEI, histidine groups improved the endosomal release of peptide carriers, and a PEGylated polyamine nanogel (PDEAMA) triggered endosomal escape through its buffering capacity [53, 54] . An interesting alternative mechanism is exerted by PAMAM dendrimers that expand their volume with decreasing pH eventually resulting in endosome rupture [55] . Unfortunately, including membrane disruptive molecules can increase the toxicity of the transfection agent and a good balance between transfection efficiency and cytotoxicity is sometimes difficult to achieve. Therefore, exosomes are superior over synthetic carriers when endosomal release is considered, especially in the context of balancing cytotoxicity.
[ and released again to repeatedly traverse single cells [26] .
Synthetic nanocomplexes show a tendency to accumulate in the liver [34] . However, incorporation of ligands increased targeting to specific cells and tissues. PEI was modified with folate to be taken up by folate receptor expressing tumors [42], or by pullulan, a water-soluble polysaccharide, to direct it to [60] . Both linear and branched PEI induced proinflammatory cytokine production and hepatic damage, although linear PEI was less toxic [61] . For several other synthetic carrier systems like chitosan, cyclodextrin, or polypeptides low toxicity was reported. In general, there seems to exist an inverse relation between biodegradability and toxicity. Polycations containing crosslinking disulfide bonds which make them reducible showed significantly lower cytotoxicity than a conventional high molecular weight PEI [62] .
In comparison to the use of other nanoparticle delivery vehicles, exosomes show a very favourable toxicity profile.
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Transfection efficiency and gene regulatory activity
The efficiency of gene silencing after the application of exosomes depends on a variety of factors which are not yet well explored. Most importantly however, exosomes showed in vivo gene regulatory activity even in the brain, a notoriously difficult to target tissue [26] . In this study, exosomes were equipped with the already mentioned RVG-Lamp2b fusion protein and prepared from immature murine dendritic cells. Exosomes were loaded by electroporation with a siRNA against β-amyloid cleaving enzyme (BACE1), which is involved in the pathogenesis of Alzheimer's disease. Systemic delivery of these exosomes resulted in BACE1 inhibition and a significant decrease in β-amyloid levels in the brain. In another study, intravenously injected exosomes containing the tumor-suppressive Let-7a miRNA were able to reduce tumor growth in a murine breast cancer model by 40% [56] . Targeting was achieved by incorporation of a peptide which bound to the epithelial growth factor receptor. To date, only very few studies describe exosome-mediated in vivo siRNA transfection.
The simpler synthetic transfection systems which reach reasonably high transfection efficiency in cell cultures showed very limited success rates in vivo. More advanced modular scaffolds integrating components which implicate higher serum stability, better targeting, as well as enhanced cellular uptake and intracellular release, reach significant transfection efficiency and gene silencing [21] . As already mentioned, the liver is the organ with the best results, but also cancer tissue has been successfully targeted e.g. by PEG-LHRH peptide coated dendrimers [45] . 
Bio-degradability and toxicity
The pioneering study by Alvarez-Erviti et al. [26] showed that systemically applied exosomes did not accumulate in the liver.
In addition, several Phase I clinical trials using exosomes as a therapeutic cancer vaccine showed that repeated application of exosomes was well-tolerated in patients with no severe toxic side-effects [57] [58] [59] . Exosomes can thus be considered as non toxic transfection vehicles.
Positively charged synthetic nanoparticles form aggregates with the negatively charged serum proteins which then accumulate in the liver, lung and spleen resulting in impaired organ function [34] . Lipoplex accumulation in the lung can induce pulmonary toxicity associated with inflammation [28] . Branched PEI is biologically nondegradable leading to high cytotoxicity
